592
     RDKit          2D

 16 16  0  0  0  0  0  0  0  0999 V2000
    2.3645   -0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3645    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  5  1  0
  4  6  1  0
  1  7  1  0
  2  8  1  0
  3  9  1  0
  3 10  1  0
  4 11  1  0
  4 12  1  0
  5 13  1  0
  5 14  1  0
  6 15  1  0
  6 16  1  0
M  END
>  <ALOGPS_LOGP>  (1) 
-1.16

>  <ALOGPS_LOGS>  (1) 
0.63

>  <ALOGPS_SOLUBILITY>  (1) 
3.71e+02 g/l

>  <DATABASE_ID>  (1) 
DB00592

>  <DATABASE_NAME>  (1) 
drugbank

>  <DRUGBANK_ID>  (1) 
DB00592

>  <DRUG_GROUPS>  (1) 
approved; vet_approved

>  <EXACT_MASS>  (1) 
86.08439833

>  <FORMULA>  (1) 
C4H10N2

>  <GENERIC_NAME>  (1) 
Piperazine

>  <INCHI_IDENTIFIER>  (1) 
InChI=1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2

>  <INCHI_KEY>  (1) 
GLUUGHFHXGJENI-UHFFFAOYSA-N

>  <INTERNATIONAL_BRANDS>  (1) 
Antepar; Uvilon; Vermidol; Vermizine

>  <JCHEM_ACCEPTOR_COUNT>  (1) 
2

>  <JCHEM_AVERAGE_POLARIZABILITY>  (1) 
9.973273418817676

>  <JCHEM_BIOAVAILABILITY>  (1) 
1

>  <JCHEM_DONOR_COUNT>  (1) 
2

>  <JCHEM_FORMAL_CHARGE>  (1) 
0

>  <JCHEM_GHOSE_FILTER>  (1) 
0

>  <JCHEM_IUPAC>  (1) 
piperazine

>  <JCHEM_LOGP>  (1) 
-0.72880683

>  <JCHEM_MDDR_LIKE_RULE>  (1) 
0

>  <JCHEM_NUMBER_OF_RINGS>  (1) 
1

>  <JCHEM_PHYSIOLOGICAL_CHARGE>  (1) 
1

>  <JCHEM_PKA_STRONGEST_BASIC>  (1) 
9.559244671699773

>  <JCHEM_POLAR_SURFACE_AREA>  (1) 
24.06

>  <JCHEM_REFRACTIVITY>  (1) 
25.4488

>  <JCHEM_ROTATABLE_BOND_COUNT>  (1) 
0

>  <JCHEM_RULE_OF_FIVE>  (1) 
1

>  <JCHEM_TRADITIONAL_IUPAC>  (1) 
piperazine

>  <JCHEM_VEBER_RULE>  (1) 
1

>  <MOLECULAR_WEIGHT>  (1) 
86.1356

>  <PRODUCTS>  (1) 
Entacyl Granules; Entacyl Granules 2.0gm; Entacyl Susp 0.6gm/5ml; Entacyl Suspension-600mg/5ml; Formule C34; Veriga 125; Vermirex Syr; Versol 100mg

>  <SALTS>  (1) 
Piperazine adipate; Piperazine citrate; Piperazine hexahydrate; Piperazine hydrate; Piperazine hydrochloride; Piperazine monohydrochloride; Piperazine phosphate; Piperazine sulfate

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
APRD00225; DB11514

>  <SMILES>  (1) 
C1CNCCN1

>  <SYNONYMS>  (1) 
Diethylenediamine; Piperazidine; Piperazin

$$$$
